Obesity in children and hypertension;Obesità in età pediatrica ed ipertensione arteriosa

Giornale Italiano di Cardiologia

Volumn 9, Issue 6, 2008, Pages 394-401

  di Salvo, Giovanni ^a,c   Pacileo, Giuseppe ^a   del Giudice, Emanuele Miraglia ^b   Rea, Alessandra ^a   Natale, Francesco ^a   Castaldi, Biagio ^a   Gala, Simona ^a   Fratta, Fiorella ^a   Limongelli, Giuseppe ^a   Calabrò, Paolo ^a   Perrone, Laura ^b   Calabrò, Raffaele ^a  

^a Divisione di Cardiologia Pediatrica   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c NONE   (Italy)

Author keywords

Childhood; Hypertension; Obesity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; TROGLITAZONE;

CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD NUTRITION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FAST FOOD; FOOD INTAKE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORTHOPEDICS; PREVALENCE; REVIEW; SLEEP APNEA SYNDROME; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; CHILD; HUMANS; HYPERTENSION; OBESITY; RISK FACTORS;

EID: 48249119552     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Ogden CL, Troiano RP, Briefel RR, Kuczmarski RJ, Flegal KM, Johnson CL. Prevalence of overweight among preschool children in the United States, 1971 through 1994. Pediatrics 1997; 99: E1.
2. Istituto Nazionale di Statistica (ISTAT). Indagine sullo stato di salute e ricorso ai servizi sanitari 1999-2000. Roma: ISTAT, 2001.
3. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-77.
4. Chiolero A, Bovet P, Paradis G, Paccaud F. Has blood pressure increased in children in response to the obesity epidemic? Pediatrics 2007; 119: 544-53.
5. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103 (6 Pt 1): 1175-82.
6. Rocchini AP, Moorehead C, Wentz E, Deremer S. Obesity-induced hypertension in the dog. Hypertension 1987; 9 (6 Pt 2): III64-III68.
7. Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150: 153-62.
8. Dahl LK, Silver L, Christie RW. The role of salt in the fall of blood pressure accompanying reduction in obesity. N Engl J Med 1958; 258: 1186-92.
9. Rocchini AP, Key J, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321: 580-5.
10. Dornfeld LP, Maxwell MH, Waks AU, Schroth P, Tuck ML. Obesity and hypertension: long-term effects of weight reduction on blood pressure. Int J Obes 1985; 9: 381-9.
11. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
12. Troisi RJ, Weiss ST, Segal MR, Cassano PA, Vokonas PS, Landsberg L. The relationship of body fat distribution to blood pressure in normotensive men: the normative aging study. Int J Obes 1990; 14: 515-25.
13. Rocchini AP, Katch V, Kveselis D, et al. Insulin and renal sodium retention in obese adolescents. Hypertension 1989; 14: 367-74.
14. Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest 1980; 65: 1272-84.
15. Sechi LA. Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens 1999; 17: 1229-37.
16. Hall JE, Brands MW, Henegar JR, Shek EW. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25: 58-64.
17. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17.
18. Voors AW, Radhakrishnamurthy B, Srinivasan SR, Webber LS, Berenson GS. Plasma glucose level related to blood pressure in 272 children, ages 7-15 years, sampled from a total biracial population. Am J Epidemiol 1981; 113: 347-56.
19. Julius S, Majahalme S, Nesbitt S, et al. A "gender blind" relationship of lean body mass and blood pressure in the Tecumseh study. Am J Hypertens 2002; 15: 258-63.
20. Sharma V, McNeill JH. The etiology of hypertension in the metabolic syndrome part four: the systemic perspective - the role of the neuroendocrine and immune systems, and the challenge of integration. Curr Vasc Pharmacol 2006; 4: 349-81.
21. Rocchini AP, Katch V, Schork A, Kelch RP. Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987; 10: 267-73.
22. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623-34.
23. Aggoun Y, Tounian P, Dabbas-Tyan M, et al. Arterial rigidity and endothelial dysfunction in obese children. Arch Mal Coeur Vaiss 2002; 95: 631-5.
24. Funahashi T, Matsuzawa Y. Metabolic syndrome: clinical concept and molecular basis. Ann Med 2007; 39: 482-94.
25. Reaven GM, Ho H, Hoffman BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988; 12: 129-32.
26. Reaven GM, Ho H, Hoffmann BB. Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989; 14: 117-20.
27. McCarty MF. PKC-mediated modulation of L-type calcium channels may contribute to fat-induced insulin resistance. Med Hypotheses 2006; 66: 824-31.
28. Mondon CE, Reaven GM. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988; 37: 303-5.
29. Weidmann P. Pressor factors and cardiovascular pressor responsiveness in essential hypertension. Int J Obes 1981; 5 (Suppl 1): 51-67.
30. Reaven GM, Chang H, Hoffman BB, Azhar S. Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 1989; 38: 1155-60.
31. Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K. Central obesity and coronary heart disease in men. Lancet 1987; 1: 821-4.
32. Kortelainen ML. Adiposity, cardiac size and precursors of coronary atherosclerosis in 5 to 15-year-old children: a retrospective study of 210 violent deaths. Int J Obes Relat Metab Disord 1997; 21: 691-7.
33. MacMahon SW, Wilcken DE, Macdonald GJ. The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 1986; 314: 334-9.
34. Alpert MA, Singh A, Terry BE, Kelly DL, Villarreal D, Mukerji V. Effect of exercise on left ventricular systolic function and reserve in morbid obesity. Am J Cardiol 1989; 63: 1478-82.
35. de Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M. Obesity and cardiac function. Circulation 1981; 64: 477-82.
36. Urbina EM, Gidding SS, Bao W, Pickoff AS, Berdusis K, Berenson GS. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa Heart Study. Circulation 1995; 91: 2400-6.
37. Daniels SR, Kimball TR, Morrison JA, Khoury P, Witt S, Meyer RA. Effect of lean body mass, fat mass, blood pressure, and sexual maturation on left ventricular mass in children and adolescents. Statistical, biological, and clinical significance. Circulation 1995; 92: 3249-54.
38. Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 1998; 97: 1907-11.
39. Schmieder RE, Messerli FH. Does obesity influence early target organ damage in hypertensive patients? Circulation 1993; 87: 1482-8.
40. Di Salvo G, Pacileo G, Del Giudice EM, et al. Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study. Eur Heart J 2006; 27: 2689-95.
41. Messerli FH, Nunez BD, Ventura HO, Snyder DW. Overweight and sudden death: increased ventricular ectopy in cardiopathy in obesity. Arch Intern Med 1987; 147: 1725-8.
42. Nakajima T, Fujioka S, Tokunaga K, Matsuzawa Y, Tarui S. Correlation of intraabdominal fat accumulation and left ventricular performance in obesity. Am J Cardiol 1989; 64: 369-73.
43. Becque MD, Katch VL, Rocchini AP, Marks CR, Moorehead C. Coronary risk incidence of obese adolescents: reduction by exercise plus diet intervention. Pediatrics 1988; 81: 605-12.
44. McMahan CA, Gidding SS, Viikari JS, et al. Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). Am J Cardiol 2007; 100: 1124-9.
45. Avelar E, Cloward TV, Walker JM, et al. Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxernia, and body mass. Hypertension 2007; 49: 34-9.
46. Ardissino G, Edefonti A, Bianchetti MG, et al. Criteri diagnostici e terapeutici dell'ipertensione arteriosa in età pediatrica. G Ital Nefrol 2006; 23: 149-62.
47. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl): 555-76.
48. Stabouli S, Kotsis V, Zakopoulos N. Ambulatory blood pressure monitoring and target organ damage in pediatrics. J Hypertens 2007; 25: 1979-86.
49. Daniels SR. Obesity in the pediatric patient: cardiovascular complications. Prog Pediatr Cardiol 2001; 12: 161-7.
50. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-608.
51. Hagberg JM, Goldring D, Ehsani AA, et al. Effect of exercise training on the blood pressure and hemodynamic features of hypertensive adolescents. Am J Cardiol 1983; 52: 763-8.
52. Hagberg JM, Goldring D, Health OW, Ehseni AA, Hernandez A, Holloszy JO. Effect of exercise training on plasma catecholamines and haemodynamics of adolescent hypertensives during rest, submaximal exercise and orthostatic stress. Clin Physiol 1984; 4: 117-24.
53. Hansen HS, Froberg K, Hyldebrandt N, Nielsen JR. A controlled study of eight months of physical training and reduction of blood pressure in children: the Odense school-child study. BMJ 1991; 303: 682-5.
54. Alpert BS. Exercise as a therapy to control hypertension in children. Int J Sports Med 2000; 21 (Suppl 2): S94-S97.
55. Salmon J, Shilton T. Endorsement of physical activity recommendations for children and youth in Australia. J Sci Med Sport 2004; 7: 405-6.
56. Di Salvo G, Perrone L, Calabrò R. Traditional diet: hope for our children [author reply]. Eur Heart J 2007; 28: 638-9.
57. Ryan DH, Bray GA, Helmcke F, et al. Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Obes Res 1999; 7: 313-22.
58. Ferdinand KC. Update in pharmacologic treatment of hypertension. Cardiol Clin 2001; 19: 279-94.
59. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
60. Wells T, Rippley R, Hogg R, et al. The pharmacokinetics of enalapril in children and infants with hypertension. J Clin Pharmacol 2001; 41: 1064-74.
61. Shahinfar S, Cano F, Soffer BA, et al. A double-blind, dose-response study of losartan in hypertensive children. Am J Hypertens 2005; 18 (2 Pt 1): 183-90.
62. Jones KL, Arslanian S. Peterokova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25: 89-94.
63. Basu A, Jensen MD, McCann F, Mukhopadhyay D, Joyner MJ, Rizza RA. Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes. Diabetes Care 2006; 29: 510-4.
64. Flynn JT, Daniels SR. Pharmacologic treatment of hypertension in children and adolescents. J Pediatr 2006; 149: 746-54.